Overview
ARQT market data
Price History
ARQT price chart · 1M
- O
- 23.37
- H
- 24.02
- L
- 23.37
- C
- 23.88
- Vol
- 67,874.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $23.37
- Previous Close
- $23.66
- Day High
- $24.02
- Day Low
- $23.37
- 52 Week High
- $29.81
- 52 Week Low
- $19.30
- 7 Day Return
- +0.42%
- 30 Day Return
- -11.51%
- 90 Day Return
- +10.84%
- 1 Year Return
- +12.35%
- Daily Notional Volume
- $1.6M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 105.33 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.13 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.70 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 6.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.21 – $31.77 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $3B · P/B 18.77 · P/S 6.47.
Company News
10 captured
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Globenewswire Inc ·
Arcutis Management to Present at the Morgan Stanley 24th Annual Global Healthcare ConferenceGlobenewswire Inc ·
Morgan Stanley Maintains Overweight on Arcutis Biotherapeutics, Raises Price Target to $38Benzinga ·